Aimei Health Technology Co., Ltd
AFJK
$11.30
$0.090.80%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | -- | -- | -- | |
Cost of Revenue | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | |
SG&A Expenses | -86.54% | 169.14% | 928.13% | 8,486.11% | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | -86.54% | 169.14% | 928.13% | 8,486.11% | |
Operating Income | 86.54% | -169.14% | -928.13% | -8,486.11% | |
Income Before Tax | -30.22% | -75.55% | 70.35% | 17,019.44% | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -30.22% | -75.55% | 70.35% | 17,019.44% | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -30.22% | -75.55% | 70.35% | 17,019.44% | |
EBIT | 86.54% | -169.14% | -928.13% | -8,486.11% | |
EBITDA | -- | -- | -- | -- | |
EPS Basic | 2.81% | -69.65% | -2.19% | 2,427.59% | |
Normalized Basic EPS | 2.84% | -69.79% | -1.91% | 2,444.44% | |
EPS Diluted | 2.81% | -69.65% | -2.19% | 2,427.59% | |
Normalized Diluted EPS | 2.84% | -69.79% | -1.91% | 2,444.44% | |
Average Basic Shares Outstanding | -32.18% | -19.31% | 74.08% | 622.08% | |
Average Diluted Shares Outstanding | -32.18% | -19.31% | 74.08% | 622.08% | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |